Deng, PhD, X. et al. 2017. Screening Genetic Alterations of Biomarkers BRAF, ROS-1, and HER2 by Immunohistochemistry in Ovarian Carcinomas for Targeted Therapy. North American Journal of Medicine and Science. 10, 2 (Apr. 2017).